← Leaderboards
Jordan M Winter
Thomas Jefferson University
$3,794,444
Attributed
$4,470,438
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,470,438 · 3
By mechanism
R37$2,731,594 · 1
R01$1,351,989 · 1
R21$386,855 · 1
Top collaborators
- Jonathan Brody2 shared
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Anna Pluciennik$3,326,266
- Nathaniel W. Snyder$5,947,517
- Jonathan Brody$5,162,616
- Wayne E Childers$697,333
- Aditi Jain$156,000
Others in their field
Top investigators on “Mouse Model”
- Dennis R. Burton · Scripps Research Institute$280,661,242
- David Heimbrook · Leidos Biomedical Research, Inc.$84,491,283
- Kc Kent Lloyd · University Of California At Davis$74,285,556
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Stanley B Prusiner · University Of California San Francisco$61,905,394
- Ed Lein · Allen Institute$59,425,748
Research focus
Mouse ModelMetabolicChemotherapyPharmaceutical PreparationsMolecularMalignant Neoplasm Of PancreasPancreatic Ductal AdenocarcinomaTumorCell LineEnzymesMalignant NeoplasmsAntioxidantsMitochondriaCessation Of LifeMetabolismIsocitratesGlucoseIn VivoLeadInsightBiologyAlpha KetoglutarateExhibitsCells
Grant awards (11)
Optimizing anti-wild-type IDH1 therapy in pancreatic cancer$661,060
R01 · FY2025 · CA · contact PI
Optimizing anti-wild-type IDH1 therapy in pancreatic cancer$690,929
R01 · FY2024 · CA · contact PI
Targeting pancreatic cancer's metabolic addiction to HuR$418,473
R37 · FY2024 · CA · contact PI
Targeting pancreatic cancer's metabolic addiction to HuR$431,688
R37 · FY2023 · CA · contact PI
Targeting pancreatic cancer's metabolic addiction to HuR$373,116
R37 · FY2022 · CA · contact PI
Targeting pancreatic cancer's metabolic addiction to HuR$373,116
R37 · FY2021 · CA · contact PI
Targeting pancreatic cancer's metabolic addiction to HuR$373,116
R37 · FY2020 · CA · contact PI
Targeting pancreatic cancer's metabolic addiction to HuR$360,601
R37 · FY2019 · CA · contact PI
Targeting pancreatic cancer's metabolic addiction to HuR$401,484
R37 · FY2018 · CA · contact PI
MUC1-Targeted Nanotherapy for Pancreatic Cancer$167,112
R21 · FY2014 · CA · contact PI
MUC1-Targeted Nanotherapy for Pancreatic Cancer$219,743
R21 · FY2013 · CA · contact PI